Femasys Inc (FEMY)

Currency in USD
4.0400
-0.1500(-3.58%)
Closed·
4.04000.0000(0.00%)
·
FEMY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.85004.3300
52 wk Range
3.770022.2000
Key Statistics
Prev. Close
4.19
Open
4.29
Day's Range
3.85-4.33
52 wk Range
3.77-22.2
Volume
43.79K
Average Volume (3m)
60.08K
1-Year Change
-77.0455%
Book Value / Share
2.41
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FEMY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
63.3333
Upside
+1,467.66%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Femasys Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 63.3333
(+1,467.66% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street
Buy1.50-62.87%-New CoverageMar 03, 2026
Laidlaw
Buy6.50+60.89%-New CoverageNov 20, 2025
H.C. Wainwright
Buy12.00+197.03%-MaintainJun 26, 2025

Earnings

Latest Release
May 08, 2026
EPS / Forecast
-- / -1.80
Revenue / Forecast
424.89K / 605.5K
EPS Revisions
Last 90 days

FEMY Income Statement

Compare FEMY to Peers and Sector

Metrics to compare
FEMY
Peers
Sector
Relationship
P/E Ratio
−1.1x−5.6x−0.5x
PEG Ratio
−0.01−0.290.00
Price/Book
1.7x4.3x2.6x
Price / LTM Sales
5.3x2.7x3.0x
Upside (Analyst Target)
-35.4%58.6%
Fair Value Upside
Unlock0.0%10.2%Unlock

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women’s reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
107.09K3.55%448.71K
Other Institutional Investors
987.79K32.71%4.14M
Public Companies & Retail Investors
1.92M63.74%8.06M
Total
3.02M100.00%12.65M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dauntless Investment Group, Llc9.99%6,033,03025,278
Alumni Capital Management7.90%4,773,57920,001

People Also Watch

7.210
RXT
-4.25%
1.9900
HUBC
+6.42%
185.00
SPCX
-3.56%
10.3193
MNTS
+2.58%
2.010
QTEX
+5.79%

FAQ

What Is the Femasys (FEMY) Stock Price Today?

The Femasys stock price today is 4.0400 USD.

What Stock Exchange Does Femasys Trade On?

Femasys is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Femasys?

The stock symbol for Femasys is "FEMY."

What Is the Femasys Market Cap?

As of today, Femasys market cap is 12.1700M USD.

What Is Femasys's Earnings Per Share (TTM)?

The Femasys EPS (TTM) is -4.7600.

When Is the Next Femasys Earnings Date?

Femasys will release its next earnings report on Aug 12, 2026.

From a Technical Analysis Perspective, Is FEMY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Femasys Stock Split?

Femasys has split 1 times.

How Many Employees Does Femasys Have?

Femasys has 53 employees.

What is the current trading status of Femasys (FEMY)?

As of Jun 18, 2026, Femasys (FEMY) is trading at a price of 4.0400 USD, with a previous close of 4.1900 USD. The stock has fluctuated within a day range of 3.8500 USD to 4.3300 USD, while its 52-week range spans from 3.7700 USD to 22.2000 USD.

What Is Femasys (FEMY) Price Target According to Analysts?

The average 12-month price target for Femasys is 63.3333 USD, with a high estimate of 130 USD and a low estimate of 30 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +1,467.66% Upside potential.

What Is the FEMY Premarket Price?

FEMY's last pre-market stock price is 4.1400 USD. The pre-market share volume is 660.0000, and the stock has decreased by -0.0500, or -1.1900%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.